Articles tagged with "safety warning"

Safety Risk with Higher Dose Tofacitnib

March 6, 2019 • By Michele B. Kaufman, PharmD, BCGP

FDA Update: Priority Review for Non-Opioid Treatment & New Warning for Fluoroquinolones

January 23, 2019 • By Michele B. Kaufman, PharmD, BCGP

Second Biosimilar Equivalent to Adalimumab

November 9, 2016 • By Michele B. Kaufman, PharmD, BCGP

FDA Update: New Boxed Warnings for Opioids & Benzodiazepines; Plus New Drug Safety Labeling Changes Database

October 5, 2016 • By Michele B. Kaufman, PharmD, BCGP

Patients with OA Respond to Low-Dose SoluMatrix Meloxicam; Off-Label Use of Ketoconazole Results in Death

June 8, 2016 • By Michele B. Kaufman, PharmD, BCGP

FDA Restricts Use of Systemic Fluoroquinolones Due to Side Effects & Will Review Application of Apadaz for Pain

June 1, 2016 • By Michele B. Kaufman, PharmD, BCGP

FDA Warns Makers of Superbug-Prone Scopes over Testing Violations

August 18, 2015 • By Reuters Staff

FDA Strengthens Warning Label for Certain Antiinflammatory Drugs

July 14, 2015 • By Reuters Staff